Logo image of GAUZ

GAUZY LTD (GAUZ) Stock Fundamental Analysis

NASDAQ:GAUZ - Nasdaq - IL0012050121 - Common Stock - Currency: USD

6.24  +0.07 (+1.13%)

Fundamental Rating

2

GAUZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. GAUZ has a bad profitability rating. Also its financial health evaluation is rather negative. GAUZ is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GAUZ has reported negative net income.
GAUZ had a negative operating cash flow in the past year.
GAUZ Yearly Net Income VS EBIT VS OCF VS FCFGAUZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

GAUZ's Return On Assets of -37.69% is on the low side compared to the rest of the industry. GAUZ is outperformed by 82.26% of its industry peers.
The Return On Equity of GAUZ (-130.36%) is worse than 85.48% of its industry peers.
Industry RankSector Rank
ROA -37.69%
ROE -130.36%
ROIC N/A
ROA(3y)-45.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GAUZ Yearly ROA, ROE, ROICGAUZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

GAUZ has a Gross Margin (28.92%) which is in line with its industry peers.
In the last couple of years the Gross Margin of GAUZ has remained more or less at the same level.
GAUZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
GAUZ Yearly Profit, Operating, Gross MarginsGAUZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

1

2. Health

2.1 Basic Checks

GAUZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
GAUZ has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, GAUZ has an improved debt to assets ratio.
GAUZ Yearly Shares OutstandingGAUZ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
GAUZ Yearly Total Debt VS Total AssetsGAUZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

GAUZ has an Altman-Z score of -1.80. This is a bad value and indicates that GAUZ is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.80, GAUZ is not doing good in the industry: 82.26% of the companies in the same industry are doing better.
GAUZ has a Debt/Equity ratio of 0.64. This is a neutral value indicating GAUZ is somewhat dependend on debt financing.
GAUZ has a worse Debt to Equity ratio (0.64) than 80.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z -1.8
ROIC/WACCN/A
WACC8.19%
GAUZ Yearly LT Debt VS Equity VS FCFGAUZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 0.81 indicates that GAUZ may have some problems paying its short term obligations.
GAUZ has a Current ratio of 0.81. This is amonst the worse of the industry: GAUZ underperforms 95.16% of its industry peers.
GAUZ has a Quick Ratio of 0.81. This is a bad value and indicates that GAUZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.53, GAUZ is doing worse than 95.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.53
GAUZ Yearly Current Assets VS Current LiabilitesGAUZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.11% over the past year.
Looking at the last year, GAUZ shows a very strong growth in Revenue. The Revenue has grown by 32.76%.
Measured over the past years, GAUZ shows a very strong growth in Revenue. The Revenue has been growing by 141.92% on average per year.
EPS 1Y (TTM)1.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.2%
Revenue 1Y (TTM)32.76%
Revenue growth 3Y141.92%
Revenue growth 5YN/A
Sales Q2Q%-9.55%

3.2 Future

Based on estimates for the next years, GAUZ will show a very strong growth in Earnings Per Share. The EPS will grow by 25.39% on average per year.
GAUZ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.83% yearly.
EPS Next Y74.04%
EPS Next 2Y38.95%
EPS Next 3Y25.39%
EPS Next 5YN/A
Revenue Next Year26.83%
Revenue Next 2Y36.9%
Revenue Next 3Y40.83%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GAUZ Yearly Revenue VS EstimatesGAUZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
GAUZ Yearly EPS VS EstimatesGAUZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GAUZ. In the last year negative earnings were reported.
Also next year GAUZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GAUZ Price Earnings VS Forward Price EarningsGAUZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GAUZ Per share dataGAUZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as GAUZ's earnings are expected to grow with 25.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.95%
EPS Next 3Y25.39%

More info and screens

0

5. Dividend

5.1 Amount

GAUZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GAUZY LTD

NASDAQ:GAUZ (8/8/2025, 8:00:00 PM)

6.24

+0.07 (+1.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-13 2025-08-13/bmo
Inst Owners32.42%
Inst Owner ChangeN/A
Ins Owners2.51%
Ins Owner ChangeN/A
Market Cap116.94M
Analysts80
Price Target12.24 (96.15%)
Short Float %1.61%
Short Ratio1.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.77%
Min EPS beat(2)-51.19%
Max EPS beat(2)27.65%
EPS beat(4)1
Avg EPS beat(4)-93.34%
Min EPS beat(4)-331.37%
Max EPS beat(4)27.65%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-8.96%
Min Revenue beat(2)-18.51%
Max Revenue beat(2)0.58%
Revenue beat(4)2
Avg Revenue beat(4)-6.62%
Min Revenue beat(4)-18.51%
Max Revenue beat(4)2.62%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-31.02%
EPS NY rev (1m)0%
EPS NY rev (3m)3.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.16
P/FCF N/A
P/OCF N/A
P/B 3.01
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.98
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-2
FCFYN/A
OCF(TTM)-1.36
OCFYN/A
SpS5.4
BVpS2.08
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.69%
ROE -130.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.92%
FCFM N/A
ROA(3y)-45.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 164.39%
Cap/Sales 11.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.53
Altman-Z -1.8
F-Score5
WACC8.19%
ROIC/WACCN/A
Cap/Depr(3y)114.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.2%
EPS Next Y74.04%
EPS Next 2Y38.95%
EPS Next 3Y25.39%
EPS Next 5YN/A
Revenue 1Y (TTM)32.76%
Revenue growth 3Y141.92%
Revenue growth 5YN/A
Sales Q2Q%-9.55%
Revenue Next Year26.83%
Revenue Next 2Y36.9%
Revenue Next 3Y40.83%
Revenue Next 5YN/A
EBIT growth 1Y3.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year106.14%
EBIT Next 3Y51.14%
EBIT Next 5YN/A
FCF growth 1Y-17.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.54%
OCF growth 3YN/A
OCF growth 5YN/A